Literature DB >> 16451408

Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.

K B Laupland1, T Ross, D L Church, D B Gregson.   

Abstract

Pyogenic streptococci are a major cause of invasive infection. This study presents the results of a population-based laboratory surveillance for invasive pyogenic streptococcal infections among residents of the Calgary Health Region (population 1 million) between 1 July 1999 and 30 June 2004. The overall annual incidence rate was 18.65/100,000 population, with isolates belonging to the Streptococcus milleri group forming the most important aetiology (incidence of 8.65/100,000 population). Invasive infection with groups A, B, G and C streptococci occurred at annual rates of 4.27, 3.13, 1.83 and 0.41/100,000 population, respectively. There was a close relationship between increasing age and development of an invasive pyogenic streptococcal infection, and the incidence of infection was higher among males than among females. Differences in the seasonal occurrence and focus of infection occurred between the different groups.

Entities:  

Mesh:

Year:  2006        PMID: 16451408     DOI: 10.1111/j.1469-0691.2005.01345.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  27 in total

1.  Phage 3396 from a Streptococcus dysgalactiae subsp. equisimilis pathovar may have its origins in streptococcus pyogenes.

Authors:  Mark R Davies; David J McMillan; Gary H Van Domselaar; Malcolm K Jones; Kadaba S Sriprakash
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

2.  Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

Authors:  George E Nelson; Tracy Pondo; Karrie-Ann Toews; Monica M Farley; Mary Lou Lindegren; Ruth Lynfield; Deborah Aragon; Shelley M Zansky; James P Watt; Paul R Cieslak; Kathy Angeles; Lee H Harrison; Susan Petit; Bernard Beall; Chris A Van Beneden
Journal:  Clin Infect Dis       Date:  2016-04-22       Impact factor: 9.079

3.  A rare case of pyogenic pericarditis secondary to Streptococcus constellatus.

Authors:  Sehem Ghazala; Todd Rabkin Golden; Sumaya Farran; Tirdad T Zangeneh
Journal:  BMJ Case Rep       Date:  2018-03-28

4.  Milleri group streptococcus--a stepchild in the viridans family.

Authors:  Y Siegman-Igra; Y Azmon; D Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

5.  Pyogenic Pericarditis and Cardiac Tamponade Due to Streptococcus anginosus in a Combat Theater.

Authors:  Ryan C Maves; Michael S Tripp; Tracy Franzos; Scott C Wallace; Benjamin J Drinkwine; Todd C Villines
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

Review 6.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity.

Authors:  Daniela Asam; Stefanie Mauerer; Barbara Spellerberg
Journal:  Med Microbiol Immunol       Date:  2014-11-09       Impact factor: 3.402

8.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

9.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.